BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220223T140000
DTEND;TZID=America/New_York:20220223T150000
DTSTAMP:20260718T200247
CREATED:20220211T212502Z
LAST-MODIFIED:20220211T212502Z
UID:2429637-1645624800-1645628400@patientworthy.com
SUMMARY:Mission: Cure's The Future of Chronic Pancreatitis Therapies Webinar
DESCRIPTION:The Future of Chronic Pancreatitis Therapies\nMeet two leaders at the forefront of new developments\nFebruary 23\, 2022 2:00 PM \nJoin us in conversation with industry leaders who are developing therapies for chronic pancreatitis and diabetes. \nMission: Cure encourages impact investors to fund pancreatitis therapies that would not otherwise make it out of the lab. Mission Cure Capital\, a separate impact investment company\, invests in high impact\, commercially-promising treatments for pancreatitis and its symptoms. \nJoin us to learn about this approach and learn from industry leaders who are developing therapies for chronic pancreatitis and diabetes. \nWith John Mellnik\, PhD\, CEO\, Path BioAnalytics\, and Tony Kolton\, CEO\, Regenerative Medical Solutions \nTo register\, click here.
URL:https://patientworthy.com/event/mission-cures-future-chronic-pancreatitis-therapies-webinar/
CATEGORIES:Pancreatitis
ORGANIZER;CN="Mission%3A%20Cure":MAILTO:info@mission-cure.org
END:VEVENT
END:VCALENDAR